POST Online Media Lite Edition



 

Health : Page 23

Lengthy screen time associated with childhood development delays

September 4, 2023
The amount of screen time spent by one year olds is associated with developmental delays.

UK accelerates COVID-19 vaccine programs amid growing concerns over new variant risk

September 4, 2023
Health authorities in the UK have reported an increase in cases of the highly mutable Pirola COVID-19 variant.

Blood biomarker shows 'great promise' predicting progression to Alzheimer's

September 1, 2023
Neuroscience researchers at Wayne State University published a review article that confirms the usefulness of neurofilament light (NfL) blood levels to predict the likelihood and rate of progression of neurodegeneration in Alzheimer\'s disease.

Officials announce first two human cases of West Nile virus in Massachusetts

September 1, 2023
The Massachusetts Department of Public Health (DPH) announced the first two human cases of West Nile virus (WNV) in state residents this year.

EMA recommends approval of adapted COVID-19 vaccine targeting Omicron XBB.1.5

August 31, 2023
EMA’s human medicines committee (CHMP) has recommended authorising an adapted Comirnaty vaccine targeting the Omicron XBB.1.5 subvariant.

Clusters of Salmonella Enteritidis linked to consumption of chicken meat detected in 11 EU/EEA countries

August 31, 2023
Two sub-clusters of endemic Salmonella Enteritidis ST11 have been detected with at least 134 human cases identified in 11 EU/EEA countries.

Elzonris (tagraxofusp) designated as orphan drug for BPDCN by Japanese Ministry of Health

August 31, 2023
The Menarini Group and Stemline Therapeutics announced that Nippon Shinyaku Stemline\'s development partner in Japan, received Orphan Drug Designation for tagraxofusp, from the Japanese Ministry of Health, Labor and Welfare (MHLW) for the expected indication of blastic plasmacytoid dendritic cell neoplasm (BPDCN).

Tecentriq SC (atezolizumab) now approved in Great Britain

August 30, 2023
Roche announced that Tecentriq SC (atezolizumab) has been approved by the Medicines and Healthcare products Regulatory Agency (MHRA) in Great Britain.

Microplastics infiltrate all systems of body, cause behavioral changes in mice

August 29, 2023
Microplastics are among the most pervasive pollutants on the planet, finding their way into the air, water systems and food chains around the world.

FDA approves first vaccine for pregnant women to prevent RSV in infants

August 24, 2023
The U.S. Food and Drug Administration approved Abrysvo (Respiratory Syncytial Virus Vaccine), the first vaccine approved for use in pregnant women to prevent lower respiratory tract disease (LRTD) and severe LRTD caused by respiratory syncytial virus (RSV) in infants from birth through 6 months of age.

Eye scan may detect Parkinson's up to 7 years before it's diagnosed

August 23, 2023
For the first time, scientists have identified a marker in the retina that may lead to the development of Parkinson’s disease, and it may be detected years prior to diagnosis.

Novavax's updated XBB COVID vaccine induced neutralizing responses against emerging subvariants

August 22, 2023
Novavax announced that its updated protein-based XBB COVID vaccine candidate induced neutralizing antibody responses to the EG.5.1 and XBB.1.16.6 subvariants in small animal and non-human primate studies.
<< 21 22 23 24 25 ... >>